Bacterial

Clostridium Difficile Infection

• 25 June, 2020 0

  How can bacterial toxins evolve to infect different tissues?

• 19 June, 2020 0

  Could RBX2660 be the microbiome-based solution to C. diff infection recurrence?

• 28 January, 2020 0

  FDA approves Merck & Co.’s Ebola vaccine Ervebo: January’s industry headlines

E. Coli

• 8 January, 2020 0

  Antibodies from maternal microbiota could protect newborns from infection

• 13 September, 2019 0

  Multidrug efflux systems: information on evolution and mechanisms uncovered

• 16 May, 2019 0

  E. coli created with world’s first synthetic and redesigned genome

H. Pylori

• 14 June, 2018 0

  Organoids: a new model to study infectious diseases?

• 15 February, 2018 1

  Infographic: The microbiome and infectious diseases

• 27 November, 2017 0

  Are flies a significant method of bacterial transmission?

MRSA

• 28 February, 2020 0

  The race for COVID-19 treatments and vaccines: February’s industry headlines

• 26 November, 2019 0

  New study reveals how the household environment influences MRSA spread

• 11 November, 2019 2

  Novel vaccine candidate for Staphylococcus aureus shows 80% efficacy in mice

Salmonella

• 12 October, 2020 1

  Application of bacteriophages to overcome antimicrobial resistance

• 16 November, 2018 0

  Whole-genome sequencing of Salmonella enterica Serovar Typhi reveals new antimicrobial resistant isolates

• 8 August, 2018 0

  Novel models for enteric infections – an interview with the Faherty Lab

Tuberculosis

• 5 April, 2022 0

  Unraveling the history of tuberculosis one bone at a time

• 13 August, 2020 0

  Countries with previous TB vaccine coverage show improved COVID-19 outcomes

• 11 March, 2020 0

  The role of humoral immunity in TB defense – an interview with Babak Javid